The journey from laboratory innovation to bedside care requires rigorous validation, regulatory clearance, and scalable production. Translational and clinical applications in regenerative medicine emphasize how preclinical successes evolve into clinically viable therapies. It involves refining delivery systems, validating efficacy in human models, and aligning treatments with patient-specific needs. Technologies like 3D-printed grafts, cell-based therapies, and gene-modified tissues are now being tested in controlled trials. Translational and clinical applications also address manufacturing challenges, ethical oversight, and physician training to ensure successful implementation. As more therapies reach early-phase and advanced clinical stages, the path to accessible and reliable regenerative solutions is becoming clearer and more standardized globally.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized dedifferentiated fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : New treatment of muscle regeneration through activation proliferation and differentiation of muscle stem cells (satellite cells) through mitochondrial dynamics
Ki Ji Lee , National Research Foundation & Busan, Korea, Republic of
Title : 3D in vitro model of Dupuytren’s disease
Jarmila Knitlova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic